StarTric
StarTric develops a transcatheter device designed to replicate the surgical Clover technique for the edge-to-edge repair of the tricuspid valve. The technology is delivered via a transfemoral catheter to treat patients suffering from Tricuspid Regurgitation (TR) who are at high risk for open-heart surgery. The device aims to provide a minimally invasive alternative that addresses the specific anatomy of the tricuspid valve.
Visit websiteMilan, Italy
Healthtech
Medical Devices
Cardiovascular
Funding summary
- Total raised
- €0
- Funding rounds
- 1
Investors in StarTric
Investors on record for StarTric. Click any investor to view their CAPLINK profile and funding criteria.
Fundraising for a startup like StarTric?
Explore CAPLINK's investor database of thousands of active VCs and angels.
Browse investors